B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY

• P Rodriguez-Otero,
• B Dholaria,
• E Askari,
• D Reece,
• N van de Donk,
• A Chari,
• H Goldschmidt,
• A Krishnan,
• T Martin,
• M Mateos,
• D Morillo,
• C Rodriguez,
• L Rosinol,
• J San-Miguel,
• A Balari,
• R Wäsch,
• K Weisel,
• R Verona,
• S Lin,
• T Prior,
• M Wade,
• B Weiss,
• J Goldberg,
• A Oriol,
• P Hari

Affiliations

P Rodriguez-Otero

1 Clínica Universidad de Navarra, Navarra (ES)

B Dholaria

2 Vanderbilt University Medical Center, Nashville (USA)

E Askari

3 Hospital Universitario Fundación Jiménez Díaz, Madrid (ES)

D Reece

4 Princess Margaret Cancer Centre, Toronto (CA)

N van de Donk

5 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam (NL)

A Chari

6 Mount Sinai School of Medicine, New York (USA)

H Goldschmidt

7 University Hospital Heidelberg, Internal Medicine and National Center for Tumor Diseases (NCT), Heidelberg (DE)

A Krishnan

8 City of Hope Comprehensive Cancer Center, Duarte (USA)

T Martin

9 University of California, San Francisco, San Francisco (USA)

M Mateos

10 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca (ES)

D Morillo

3 Hospital Universitario Fundación Jiménez Díaz, Madrid (ES)

C Rodriguez

11 Wake Forest University School of Medicine, Winston-Salem (USA)

L Rosinol

12 Institute of Hematology and Oncology, IDIBAPS Hospital Clínic University of Barcelona, Barcelona (ES)

J San-Miguel

1 Clínica Universidad de Navarra, Navarra (ES)

A Balari

13 Institut Català d’Oncologia – Hospitalet, IDIBELL, University of Barcelona, Barcelona (ES)

R Wäsch

14 Freiburg University Medical Center, Freiburg (DE)

K Weisel

15 University Medical Center Hamburg-Eppendorf, Hamburg (DE)

R Verona

16 Janssen Research & Development, Spring House (USA)

S Lin

16 Janssen Research & Development, Spring House (USA)

T Prior

16 Janssen Research & Development, Spring House (USA)

M Wade

16 Janssen Research & Development, Spring House (USA)

B Weiss

16 Janssen Research & Development, Spring House (USA)

J Goldberg

17 Janssen Research & Development, Raritan (USA)

A Oriol

18 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona (ES)

P Hari

19 Medical College of Wisconsin, Milwaukee (USA).